Share
HPV Testing and Pap Test Market: By Product Type (HPV test, Pap test and Co-test); By Application (Cervical cancer and Vaginal cancer); By Distribution Channel (Hospitals and clinics, Diagnostic centers and Others), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
HPV Testing and Pap Test Market is expected to surpass USD 9.10 billion by 2032 from USD 2.99 billion in 2021 at a CAGR of 7.4% in the coming years, i.e., 2022-32.
The most prevalent sexually transmitted infection in the world is caused by the papillomaviridae family's Human Papillomavirus (HPV). HPV is divided into two categories, such as low-risk HPVs and high-risk HPVs, depending on the risk involved. Cervical and vaginal cancers are now well known to be caused by high-risk strains of the HPV virus. A double-stranded DNA tumour virus called the human papillomavirus promotes the growth of epithelial cells on the cutaneous and mucosal surfaces.
HPV Testing and Pap Test Market is expected to surpass USD 9.10 billion by 2032 from USD 2.99 billion in 2021 at a CAGR of 7.4% in the coming years, i.e., 2022-32. Rising demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers is one of the main factors anticipated to propel the market for human papillomavirus testing and Pap tests over the forecast period. The market for Pap tests and human papillomavirus testing is anticipated to be driven by a number of technological developments, such as the creation of human papillomavirus type 16 and the use of various molecular markers in screening techniques.
HPV Testing and Pap Test Market is categorized on the basis of Product Type into HPV test, Pap test and Co-test. Due to its extensive adoption in screening programs, the Pap test segment led the market for HPV testing and Pap tests in 2021. Further measures to raise public knowledge about Pap tests are anticipated to fuel the segment's expansion. Initial screening using HPV tests aids in finding abnormal cells that could develop into cancer. This aids in the early detection of disease and enables medical professionals to choose from a variety of preventive and/or therapeutic measures. As a result, it is projected that the HPV testing market would expand over the forecast period.
HPV Testing and Pap Test Market is categorized on the basis of distribution channel into Hospitals and clinics, Diagnostic centers and Others. With an increase in patient load, pap test and HPV testing procedures will become more common in hospitals. Healthcare spending is rising as a result of an increased availability of cutting-edge equipment, the presence of skilled personnel, and a booming demand for relatively inexpensive diagnostic procedures. The availability of well-equipped assays and test kits for the detection of cervical and vaginal cancer in both public and private institutions, as well as the influx of numerous sophisticated technologies, will encourage the market's expansion.
Development of new screening test kits and increasing cases of cervical cancer
Due to a significant group of health-conscious consumers, the pharmaceutical business is growing and developing new screening test kits, which opens up the market for Pap and HPV tests. Additionally, the prevalence of cervical cancer cases is rising across several regions, which increases demand for screening tests for the human papillomavirus and propels market expansion. A few other HPV testing and Pap test market trends that propel market expansion include the rise in the introduction of various screening test kits and the rise in new HPV type testing kits for cervical cancer screening by various major players throughout the world.
Need for technological improvements and awareness campaigns is expected to surge demand
One of the most prevalent malignancies in women over 40 is cervical cancer. According to estimates, HPV infections cause 99% or more of occurrences of cervical cancer. One of the key factors anticipated to propel the market for HPV testing and Pap tests over the forecast period is the rising need for technologically sophisticated diagnostic treatments for screening cervical and vaginal malignancies. The market for Pap tests and HPV testing is anticipated to grow as a result of numerous technological improvements and the use of numerous molecular markers in screening methods. Furthermore, one of the key factors anticipated to propel the market for Pap tests and HPV testing during the forecast period is the growing number of awareness campaigns by various organizations for cervical cancer screening.
Modifications to regulatory standards and high pricing is likely to hamper the Market Growth
The development of the HPV testing and Pap test markets is impeded by modifications to regulatory standards for cervical cancer screening. Additionally, the global accessibility of the human papillomavirus vaccine could impede market expansion. Furthermore, high cost of testing is also likely to hamper the market for HPV testing and Pap testing in the forecasted period.
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
HPV Testing and Pap Test Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America registered a sizable share of the HPV Testing and Pap Test Market in 2021. Rising demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers is one of the main factors anticipated to propel the market for human papillomavirus testing and Pap tests over the forecast period. The market for Pap tests and human papillomavirus testing is anticipated to be driven by a number of technological developments, such as the creation of human papillomavirus type 16 and the use of various molecular markers in screening techniques.
Due to the demands placed on current laboratory services and the effectiveness of HPV-based screening in light of the rising SARS-CoV-2 admissions, the HPV testing and pap test sector saw sluggish growth in reaction to the COVID-19 pandemic. Cancer screening services were disrupted as a result of a staffing shortage and potential delays in main HPV testing breakthroughs, which adversely impacted the market's expansion during the outbreak.
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
USD 2.99 billion |
|
Revenue Forecast in 2032 |
USD 9.10 billion |
|
Growth Rate |
CAGR of 7.4% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Quantitative Units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments Covered |
Product Type, Application, Distribution channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key Companies Profiled |
Arbor vita corporation, Becton, Dickinson & Company, Qiagen NV, Diagcor Bioscience Incorporation Ltd., Enzo Biochem, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Mylab Discovery Solutions Pvt. Ltd, Seegene Inc and Other Prominent Players |
The HPV Testing and Pap Test Market size was estimated at USD 2.99 billion in 2021 and is expected to reach USD 9.10 billion in 2032
The most prevalent sexually transmitted infection in the world is caused by the papillomaviridae family's Human Papillomavirus (HPV). HPV is divided into two categories, such as low-risk HPVs and high-risk HPVs, depending on the risk involved. Cervical and vaginal cancers are now well known to be caused by high-risk strains of the HPV virus. A double-stranded DNA tumour virus called the human papillomavirus promotes the growth of epithelial cells on the cutaneous and mucosal surfaces.
he pap test and hospitals segments accounted for the larger share of the HPV Testing and Pap Test Market.
Key players in the HPV Testing and Pap Test Market are Arbor vita corporation, Becton, Dickinson & Company, Qiagen NV, Diagcor Bioscience Incorporation Ltd., Enzo Biochem, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Mylab Discovery Solutions Pvt. Ltd, Seegene Inc and Other Prominent Players.
Rising demand for technologically sophisticated diagnostic procedures for screening cervical and vaginal cancers is one of the main factors anticipated to propel the market for human papillomavirus testing and Pap tests over the forecast period.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
